Neurology News

The FDA has cleared a traumatic brain injury blood test for commercial availability, paving the way for its distribution to hospitals in the United States.

A decrease of incidence and proportion of concussions resulted from implementation of a rule in the National Hockey League forbidding hits to the head, researchers reported in JAMA Network Open.

Food insecurity was linked to an increased risk for dementia and faster memory decline among older adults, according to a study published in JAMA Network Open.

Having a higher amount of visceral abdominal fat in middle age was associated with an increased risk for developing Alzheimer’s disease, according to research presented at the annual meeting of the Radiological Society of North America.

The FDA has issued a warning against the purchase or use of products that contain tianeptine, which has been illegally sold with claims to improve brain function and treat anxiety, depression, pain, opioid use disorder and other conditions.

The first patient has been enrolled in a European phase 2b clinical trial for AD04, a novel immunotherapy for the treatment of mild Alzheimer’s disease, according to the manufacturer.

A Boston-area biopharmaceutical has announced additional positive biomarker data from a phase 1/2a study of a novel cancer vaccine immunotherapeutic intended to treat those with recurrent glioblastoma.

A systematic review and meta-analysis of studies involving suicidality among patients with Parkinson’s disease found a high prevalence of suicidal ideation as well as a two times greater risk for suicidal behavior compared with controls.

A novel MRI technique showed brain microstructure changes in people who have had COVID-19, and it traced long COVID symptoms to specific networks of the brain, according to a study.

A Boston-area biopharma company announced positive data from a phase 1a/b trial of a novel therapeutic to treat newly diagnosed glioblastoma multiforme, resulting in the initiation of a first-line phase 2b study.